SCHEMBL25847632

SCHEMBL25847632

c1ccc(-c2ccc3ccc4ccc(-c5c6ccccc6nc6c5sc5ccccc56)nc4c3n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 3/20 0.36
TNKS2 Q9H2K2 3/20 0.36
KRAS P01116 1/20 0.36
PARP1 P09874 1/20 0.35
LIMK1 P53667 2/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
ESR1 P03372 3/20 0.35
ESR2 Q92731 3/20 0.35
ACHE P22303 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
PIM1 P11309 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
HTR1A P08908 1/20 0.32
HTR7 P34969 1/20 0.32
EGFR P00533 1/20 0.32
ILK Q13418 1/20 0.32
KAT2A Q92830 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21030692 0.94 TNKS (0.38) TNKSTNKS2KRASPARP1LIMK1
SCHEMBL25847630 0.90 PARP1 (0.35) TNKSTNKS2KRASPARP1LIMK1
SCHEMBL21031437 0.86 KRAS (0.41) KRASLIMK1CDK5CDK5R1ESR1
SCHEMBL21032091 0.85 KRAS (0.38) TNKSTNKS2KRASLIMK1CDK5
SCHEMBL25847629 0.82 TOP1 (0.38) KRASESR1ESR2NPC1RAB9A
SCHEMBL21030944 0.82 MEN1 (0.41) TNKSTNKS2KRASESR1ESR2
SCHEMBL21030947 0.81 ACHE (0.42) TNKSTNKS2KRASLIMK1CDK5
SCHEMBL21032070 0.81 PARP1 (0.35) PARP1LIMK1ESR1ESR2ACHE
SCHEMBL21119865 0.80 LIMK1 (0.36) TNKSTNKS2PARP1LIMK1CDK5
SCHEMBL21031282 0.80 MEN1 (0.42) TNKSTNKS2LIMK1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 TNKS 3585/4885TNKS2 3491/4885KRAS 3523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.